Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Explore linked clinical trials.319 results · Page 1 of 13
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Gut Microbiota Structure, Functional and Metabolic Profiles, and Composite Biomarkers in ICU Adults With Refractory Enteral Feeding Intolerance | Gut Microbiota; Metabolic Profiles; Refractory Enteral Feeding Intolerance | Not yet recruiting | Not stated | 2026-10-08 | NCT07864844 | |
| Sepsis ICU Gut Microbiome Analysis | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Shock, Systemic Inflammatory Response Syndrome, toxic shock syndrome | Not yet recruiting | Not stated | 2026-10-08 | NCT07864818 | |
| Robot-Assisted vs. Video-Assisted Lobectomy for NSCLC (RAVAR) | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Active, not recruiting | Not applicable | 2026-10-06 | NCT06524427 | |
| Transcutaneous Auricular Stimulation Targeting Enteral Feeding Intolerance | Enteral Feeding Intolerance; ICU | Not yet recruiting | Not applicable | 2026-10-02 | NCT07854236 | |
| Propofol or Esketamine: Tracheal Intubation Comparison | Critically Ill Adults Requiring Emergency Tracheal Intubation in the Intensive Care Unit | Not yet recruiting | Phase 4 | 2026-09-29 | NCT07847255 | |
| Clinical Application of a Low-Dose CBCT AI Model | brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, nervous system disorder, vascular disorder | Recruiting | Not applicable | 2026-09-29 | NCT07845929 | |
| Quad Shot Radiotherapy Combined With Tislelizumab and Platinum-Based Chemotherapy Before Surgery for Stage II-III Non-Small Cell Lung Cancer | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Not yet recruiting | Phase 2 | 2026-09-29 | NCT07845916 | |
| SBRT Combined With PD-1 Inhibitor and Chemotherapy in Early-stage TNBC | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinoma | Recruiting | Phase 3 | 2026-09-29 | NCT06627712 | |
| Fosrolapitant and Palonosetron for Highly Emetogenic ADC-Induced Nausea and Vomiting in Solid Tumors | Solid Tumor Cancer | Active, not recruiting | Phase 2 | 2026-09-25 | NCT07841210 | |
| FMT for 90-Day Outcome of Clinical Use in ICU Sepsis | Critical Illness, Disease Attributes, Dysbiosis, Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Systemic Inflammatory Response Syndrome | Not yet recruiting | Not applicable | 2026-09-24 | NCT07670299 | |
| Myeloid Bias in the Bone Marrow of Septic Patients and Its Correlation With Disease Severity and Prognosis: A Single-Center, Prospective Cohort Study | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Shock, Systemic Inflammatory Response Syndrome, toxic shock syndrome | Not yet recruiting | Not stated | 2026-09-24 | NCT07667153 | |
| Efficacy and Safety of Retlirafusp Alfa Plus Bevacizumab and Chemotherapy With or Without Short-Course Radiotherapy in Patients With CRCLM | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder | Recruiting | Phase 2 | 2026-09-22 | NCT07728019 | |
| Clinical Trial on the Efficacy and Safety of ALT001 in Osteoarthritis | arthritic joint disease, arthropathy, musculoskeletal system disorder, osteoarthritis, rheumatic disorder | Active, not recruiting | Not applicable | 2026-09-22 | NCT07404891 | |
| AI-Assisted Chest CT Interpretation Across the Lung Cancer Care Continuum | Neoplasms by Site, Thoracic Neoplasms, lung cancer, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm | Not yet recruiting | Not applicable | 2026-09-21 | NCT07829640 | |
| Metabolic and Functional Study of γδ T Cells in Critically Ill Patients | Critical Illness, Disease Attributes, Dysbiosis, Infections, Inflammation, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Shock, Systemic Inflammatory Response Syndrome, inborn mitochondrial metabolism disorder, metabolic disease, multiple organ dysfunction syndrome | Recruiting | Not stated | 2026-09-17 | NCT07680816 | |
| Serplulimab Combined With Induction Chemotherapy and Radiotherapy in Nasopharyngeal Carcinoma | Locally Advanced Nasopharyngeal Carcinoma | Recruiting | Phase 3 | 2026-09-17 | NCT07177443 | |
| FMT for Feeding Intolerance Due to Gastrointestinal Dysfunction in Critically Ill Patients | Critically Ill Intensive Care Unit Patients; Feeding Intolerance; Gastrointestinal Dysfunction | Not yet recruiting | Not applicable | 2026-09-16 | NCT07640633 | |
| Atrial Shunt for the Treatment of Heart Failure With Reduced Ejection Fraction | Heart Failure With Reduced Ejection Fraction (HFrEF) | Recruiting | Phase 2 / Phase 3 | 2026-09-15 | NCT07820410 | |
| Iparomlimab and Tuvonralimab With Lenvatinib, Radiotherapy, and HAIC for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Recruiting | Phase 2 | 2026-09-15 | NCT07776080 | |
| Zanubrutinib Plus Rituximab as Front-line Treatment for Mucosa-associated Lymphoid Tissue Lymphoma (MALT) | B-cell neoplasm, Hemic and Lymphatic Diseases, Lymphoma, B-Cell, Marginal Zone, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Active, not recruiting | Phase 2 | 2026-09-15 | NCT06647732 | |
| Model Development and Application Based on Renal Pathology Images | Chronic Disease, Chronic Kidney Diseases, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, IgA glomerulonephritis, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, autoimmune disease, chronic renal failure syndrome, glomerulonephritis, immune system disorder, kidney disorder, kidney failure, membranous glomerulonephritis, nephritis, urinary system disorder | Active, not recruiting | Not stated | 2026-09-14 | NCT07816874 | |
| Dalpiciclib Combined With Aromatase Inhibitors and Olmesartan as the First-line Treatment for HR+/HER2- Advanced Breast Cancer | HR+ / HER2- Advanced Breast Cancer | Recruiting | Phase 2 | 2026-09-09 | NCT07810088 | |
| China Treatment Trial for Tumor in Sellar Region With Unruptured Intracranial Aneurysm | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Rathke Cleft Cysts, brain disorder, central nervous system cancer, central nervous system cyst, central nervous system disorder, central nervous system malformation, chordoma, craniopharyngioma, germinoma, hypothalamic disorder, hypothalamic neoplasm, meningioma, neoplasm, nervous system disorder, optic pathway glioma, primitive neuroectodermal tumor, supratentorial cancer, tumor of meninges, vascular cancer | Not yet recruiting | Not stated | 2026-09-09 | NCT07809178 | |
| Validation of a Deep Learning Tool for Opportunistic Osteoporosis Screening Using Routine Non-Contrast CT Scans | Bone Diseases, Metabolic, Nutritional and Metabolic Diseases, bone disorder, metabolic disease, musculoskeletal system disorder, osteoporosis | Active, not recruiting | Not stated | 2026-09-03 | NCT07739628 | |
| Efficacy and Safety of Colchicine After PCI | cardiovascular disorder, coronary artery disorder, heart disorder, myocardial ischemia, vascular disorder | Active, not recruiting | Phase 3 | 2026-09-03 | NCT06472908 |